Accel, a major venture capital firm backing AI companies like Anthropic and Cursor, has closed a $5 billion fundraising round to continue investing in the rapidly expanding artificial intelligence sector.
The $5 billion capital raise positions Accel to make substantial bets on AI startups as valuations in the sector continue climbing. The firm's portfolio includes some of the most prominent names in artificial intelligence development.
Anthropic, one of Accel's portfolio companies, develops Claude, a large language model competing with OpenAI's GPT models. Cursor, another backed company, offers an AI-powered code editor for developers. Perplexity, also in Accel's portfolio, operates an AI search engine.
The fundraising reflects broader investor appetite for AI ventures despite market volatility. Major venture capital firms are racing to secure larger funds to participate in what many view as a transformative technology wave.
Accel joins other leading VCs increasing their capital commitments to AI. The firm's new fund size demonstrates confidence in continued growth within the sector, even as some investors have grown cautious about valuations.
The timing aligns with increasing competition among AI startups. Multiple companies are competing across different applications—from enterprise software to consumer search tools—with significant capital requirements for training and operating large language models.
Accel's track record in AI includes early backing of successful companies, positioning the firm to attract additional limited partners and deploy capital across its portfolio. The new funds give the firm flexibility to support existing investments and identify new opportunities in the evolving AI landscape.
Venture funding for AI companies remains robust, with hundreds of billions of dollars flowing into the sector. However, investors increasingly focus on companies demonstrating clear business models and paths to profitability rather than pure technology capability.
Open-weight AI companies—those releasing freely available models—are attracting major acquisition interest from tech giants. The trend reflects growing capital investment in the business model of distributing AI models at no cost.
Google Deepmind has upgraded its Co-Scientist AI system to autonomously plan experiments, operate lab equipment, and publish scientific papers. The Gemini-based multi-agent platform demonstrated experimentally validated results across materials science, chemistry, and medical AI development.
Uber's weekly AI agent requests have grown nearly tenfold since February, yet the company has held spending flat since April after exhausting its entire 2026 AI budget in Q1.
A recent paper shows artificial intelligence often diagnoses and treats patients better than human physicians. The findings are prompting difficult conversations within the medical community about the profession's evolving role.